Melanoma vaccine (AlphaVax/Memorial Sloan-Kettering Cancer Center)

N/A

Report date: 2025/02/11 10:46:15

Base Information

Drug NameMelanoma vaccine (AlphaVax/Memorial Sloan-Kettering Cancer Center)
Drug Alias NameAlphavirus replicon vaccine expressing tyrosinase-related protein 2 antigen (AlphaVax)TRP2 melanoma vaccine (AlphaVax)
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlphavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlphavax Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A